Homeopathy 2005; 94(03): 182-195
DOI: 10.1016/j.homp.2005.03.003
Original Paper
Copyright ©The Faculty of Homeopathy 2005

The influence of childhood infections and vaccination on the development of atopy: A systematic review of the direct epidemiological evidence

UC Adler
Weitere Informationen

Publikationsverlauf

Received 19. Juli 2004
revised 08. Dezember 2004

accepted 17. März 2005

Publikationsdatum:
29. Dezember 2017 (online)

Abstract

Background The ‘hygiene hypothesis’ has been used to justify a belief common among homeopaths, that the suppression of childhood infections and immunisation may lead to the development of chronic atopic diseases.

Objectives To analyse the influence of childhood infections and immunisation on the development of atopy.

Methods Qualitative systematic review of direct epidemiological evidence (Medline 1993–2004) concerning the influence of childhood infections and immunisation on the development of atopy and discussion based on homeopathy.

Conclusions (1) Childhood infections do not protect against atopy; on the contrary, they increase the risk of allergic diseases, in agreement to Hahnemann's observations, which included epidemic diseases among the factors capable of stimulating the development of chronic diseases. (2) Vaccination is not a risk factor for atopy, notwithstanding the allergenic effect of some vaccines.

 
  • References

  • 1 Hahnemann S. Die chronischen Krankheiten, ihre eigentüml. Natur u. homöopath. Heilung, vol 1, 2a edn. Heidelberg: Haug, 1835, 4th printing, 1988, p 6.
  • 2 Stites D.P, Terr A.I, Parslow T.G. Imunologia Médica. 9a edn. Guanabara Koogan; 1997
  • 3 Lee Y.A, Wahn U, Kehrt R. et al. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet 2000; 26 (04) 470-473.
  • 4 Strachan D.P. Hay fever, hygiene and household size. BMJ 1989; 299: 1259-1260.
  • 5 Romagnani S. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 1992; 98: 279-285.
  • 6 Holt P.G. A potential vaccine strategy for asthma and allied atopic diseases during early childhood. Lancet 1994; 344: 456-458.
  • 7 Prescott S.L. Allergy: the price we pay for cleaner living?. Ann Allergy Asthma Immunol 2003; 90 (03) 64-70.
  • 8 Leynaert B, Neukirch C, Jarvis D, Chinn S, Burney P, Neukirch F. Does living on a farm during childhood protect against asthma allergic rhinitis and atopy in adulthood?. Am J Respir Crit Care Med 2001; 164: 1829-1834.
  • 9 Von Mutius E, Braun-Fahrlander C, Schierl R. et al. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 2000; 30: 1230-1234.
  • 10 Horak F, Studnicka M, Gartner C. et al. Parental farming protects children against atopy: longitudinal evidence involving skin prick tests. Clin Exp Allergy 2002; 32 (08) 1155-1159.
  • 11 Sih T.M. Vias aéreas inferiores e a poluição. J Pediatr (Rio J) 1997; 73 (03) 166-170.
  • 12 Haby M.M, Peat J.K, Marks G.B, Woolcock A.J, Leeder S.R. Asthma in preschool children: prevalence and risk factors. Thorax 2001; 56 (08) 589-595.
  • 13 Seaton A, Devereux G. Diet, infection and wheezy illness: lessons from adults. Pediatr Allergy Immunol 2000; 11 (13) 37-40.
  • 14 Teixeira M.Z. Is there scientific evidence that suppression of acute diseases in childhood induces chronic diseases in the future?. Homeopathy 2002; 91: 207-216.
  • 15 Cook D.J, Mulrow C.D, Haynes B. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 1997; 126 (05) 376-380.
  • 16 Ceran O, Aka S, Oztemel D, Uyanik B, Ozkozaci T. The relationship of tonsillar hyperplasia and asthma in a group of asthmatic children. Int J Pediatr Otorhinolaryngol 2004; 68 (06) 775-778.
  • 17 Juntti H, Kokkonen J, Dunder T, Renko M, Niinimäki A, Uhari M. Association of an early respiratory syncytial virus infection and atopic allergy. Allergy 2003; 58 (09) 878-884.
  • 18 Zejda J.E, Kowalska M. Risk factors for asthma in school children—results of a seven-year follow-up. Cent Eur J Public Health 2003; 11 (03) 149-154.
  • 19 Menendez C, Sunyer J, Ventura P.J. et al. Malaria infection does not appear to modify the risk of bronchiolitis early in life. Pediatr Infect Dis J 2002; 21 (03) 249-254.
  • 20 Lell B, Borrmann S, Yazdanbakhsh M, Kremsner P.G. Atopy and malaria. Wien Klin Wochenschr 2001; 113 23–24 927-929.
  • 21 Wickens K.L, Crane J, Kemp T.J. et al. Family size, infections, and asthma prevalence in New Zealand children. Epidemiology 1999; 10 (06) 699-705.
  • 22 Lewis S.A, Britton R.J. Measles infection, measles vaccination and the effect of birth order in the aetiology of hay fever. Clin Exp Allergy 1998; 28 (12) 1493-1500.
  • 23 Calvani M, Alessandri C, Paolone G, Rosengard L, Di Caro A, De Franco D. Correlation between Epstein Barr virus antibodies, serum IgE and atopic disease. Pediatr Allergy Immunol 1997; 8 (02) 91-96.
  • 24 Shaheen S.O, Aaby P, Hall A.J. et al. Measles and atopy in Guinea-Bissau. Lancet 1996; 347 9018 1792-1796.
  • 25 Bodner C, Anderson W.J, Reid T.S, Godden D.J. Childhood exposure to infection and risk of adult onset wheeze and atopy. Thorax 2000; 55 (05) 383-387.
  • 26 Bodner C, Godden D, Seaton A. Family size childhood infections and atopic diseases. The Aberdeen WHEASE Group. Thorax 1998; 53 (01) 28-32.
  • 27 Vonk J.M, Boezen H.M, Postma D.S, Schouten J.P, van Aalderen W.M, Boersma E.R. Perinatal risk factors for bronchial hyperresponsiveness and atopy after a follow-up of 20 years. J Allergy Clin Immunol 2004; 114 (02) 270-276.
  • 28 Camara A.A, Silva J.M, Ferriani V.P. et al. Risk factors for wheezing in a subtropical environment: role of respiratory viruses and allergen sensitization. J Allergy Clin Immunol 2004; 113 (03) 551-557.
  • 29 Chai S.K, Nga N.N, Checkoway H. et al. Comparison of local risk factors for children's atopic symptoms in Hanoi, Vietnam. Allergy 2004; 59 (06) 637-644.
  • 30 Cohet C, Cheng S, MacDonald C. et al. Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood. J Epidemiol Community Health 2004; 8 (10) 852-857.
  • 31 Gibbs S, Surridge H, Adamson R, Cohen B, Bentham G, Reading R. Atopic dermatitis and the hygiene hypothesis: a case–control study. Int J Epidemiol 2004; 33 (01) 199-207.
  • 32 Stipic-Markovic A, Pevec B, Radulovic Pevec M, Custovic A, Predovic J. Allergic diseases in relationship with environmental factors in a population of school children in Zagreb, Croatia. Arh Hig Rada Toksikol 2004; 55 2–3 221-228.
  • 33 Kramer M.S, Guo T, Platt R.W. et al. Does previous infection protect against atopic eczema and recurrent wheeze in infancy?. Clin Exp Allergy 2004; 34 (05) 753-756.
  • 34 Cullinan P, Harris J.M, Newman Taylor A.J. et al. Can early infection explain the sibling effect in adult atopy?. Eur Respir J 2003; 22 (06) 956-961.
  • 35 Linneberg A, Ostergaard C, Tvede M. et al. IgG antibodies against microorganisms and atopic disease in Danish adults: the Copenhagen Allergy Study. J Allergy Clin Immunol 2003; 111 (04) 847-853.
  • 36 Jones A.P, Eyles E. Early life exposures and the prevalence of atopic disorders in a sample of school-age infants. Monaldi Arch Chest Dis 2003; 59 (01) 38-43.
  • 37 Nuhoglu Y, Nuhoglu C, Ozcay S. The association between delayed type hypersensitivity reaction to Mycobacterium tuberculosis and atopy in asthmatic children. Allergol Immunopathol (Madr) 2003; 31 (01) 14-17.
  • 38 Sidorchuk A, Lagarde F, Pershagen G, Wickman M, Linde A. Epstein-Barr virus infection is not associated with development of allergy in children. Pediatr Infect Dis J 2003; 22 (07) 642-647.
  • 39 Olesen A.B, Juul S, Thestrup-Pedersen K. Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection. Acta Derm Venereol 2003; 83 (06) 445-450.
  • 40 Bager P, Westergaard T, Rostgaard K, Hjalgrim H, Melbye M. Age at childhood infections and risk of atopy. Thorax 2002; 57 (05) 379-382.
  • 41 McKeever T.M, Lewis S.A, Smith C. et al. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. J Allergy Clin Immunol 2002; 109 (01) 43-50.
  • 42 McKeever T.M, Lewis S.A, Smith C, Hubbard R. The importance of prenatal exposures on the development of allergic disease: a birth cohort study using the West Midlands General Practice Database. Am J Respir Crit Care Med 2002; 166 (06) 827-832.
  • 43 Schauer U, Hoffjan S, Bittscheidt J. et al. RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life. Eur Respir J 2002; 20 (05) 1277-1283.
  • 44 van der Sande M.A, Kidd I.M, Goetghebuer T. et al. Severe respiratory syncytial virus infection in early life is associated with increased type 2 cytokine production in Gambian children. Clin Exp Allergy 2002; 32 (10) 1430-1435.
  • 45 Wenzel S.E, Gibbs R.L, Lehr M.V, Simoes E.A. Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin. Am J Med 2002; 112 (08) 627-633.
  • 46 Chen C.F, Wu K.G, Hsu M.C, Tang R.B. Prevalence and relationship between allergic diseases and infectious diseases. J Microbiol Immunol Infect 2001; 34 (01) 57-62.
  • 47 Haby M.M, Peat J.K, Marks G.B, Woolcock A.J, Leeder S.R. Asthma in preschool children: prevalence and risk factors. Thorax 2001; 56 (08) 589-595.
  • 48 Suzuki N, Kudo K, Sano Y, Ito K. Can Mycobacterium tuberculosis infection prevent asthma and other allergic disorders. Int Arch Allergy Immunol 2001; 124 1–3 113-116.
  • 49 Larouch V, Rivard G, Deschesnes F, Goulet R, Turcotte H, Boulet L.P. Asthma and airway hyper-responsiveness in adults who required hospital admission for bronchiolitis in early childhood. Respir Med 2000; 94 (03) 288-294.
  • 50 Paunio M, Heinonen O.P, Virtanen M, Leinikki P, Patja A, Peltola H. Measles history and atopic diseases: a population-based cross-sectional study. JAMA 2000; 283 (03) 343-346.
  • 51 Hughes C.H, Jones R.C, Wright D.E, Dobbs F.F. A retrospective study of the relationship between childhood asthma and respiratory infection during gestation. Clin Exp Allergy 1999; 29 (10) 1378-1381.
  • 52 Ferrari M, Tardivo S, Zanolin M.E. et al. Serious childhood respiratory infections and asthma in adult life. A population based study. ECRHS Italy. European Community Respiratory Health Survey. Ann Allergy Asthma Immunol 1999; 83 (05) 391-396.
  • 53 Strannegård I.L, Larsson L.O, Wennergren G, Strannegård O. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 1998; 53 (03) 249-254.
  • 54 Sarafino E.P, Dillon J.M. Relationships among respiratory infections, triggers of attacks, and asthma severity in children. J Asthma 1998; 35 (06) 497-504.
  • 55 Nilsson L, Kjellman N.I, Björkstén B. A randomized controlled trial of the effect of pertussis vaccines on atopic disease. Arch Pediatr Adolesc Med 1998; 152 (08) 734-738.
  • 56 Aberg N, Sundell J, Eriksson B, Hesselmar B, Aberg B. Prevalence of allergic diseases in schoolchildren in relation to family history, upper respiratory infections, and residential characteristics. Allergy 1996; 51 (04) 232-237.
  • 57 Forster J, Tacke U, Krebs H. et al. Respiratory syncytial virus infection: its role in aeroallergen sensitization during the first two years of life. Pediatr Allergy Immunol 1996; 7 (02) 55-60.
  • 58 Petridou E, Kanariou M, Liatsis M. et al. Factors influencing serum immunoglobulin E levels in Greek children. Allergy 1995; 50 (03) 210-214.
  • 59 Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Björkstén B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995; 95 (04) 500-505.
  • 60 Wjst M, Dold S, Reitmeir P, Fritzsch C, von Mutius E, Thiemann H.H. Pertussis infection and allergic sensitization. Ann Allergy 1994; 73 (05) 450-454.
  • 61 Schuster A, Hofmann A, Reinhardt D. Does pertussis infection induce manifestation of allergy?. Clin Investig 1993; 71 (03) 208-213.
  • 62 Farooqi I.S, Hopkin J.M. Early childhood infection and atopic disorder. Thorax 1998; 53: 927-932.
  • 63 Droste J.H, Wieringa M.H, Weyler J.J, Nelen V.J, Vermeire P.A, Van Bever H.P. Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease?. Clin Exp Allergy 2000; 30 (11) 1547-1553.
  • 64 Strachan D.P, Butland B.K, Anderson H.R. Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ 1996; 312 7040 1195-1199.
  • 65 Asher M.I, Weiland S.K. The International Study of Asthma and Allergies in Childhood (ISAAC). ISAAC Steering Committee. Clin Exp Allergy 1998; 28 (05) 52-66.
  • 66 von Mutius E. Infection: friend or foe in the development of atopy and asthma? The epidemiological evidence. Eur Respir J 2001; 18 (05) 872-881.
  • 67 von Hertzen L.C. Puzzling associations between childhood infections and the later occurrence of asthma and atopy. Ann Med 2000; 32 (06) 397-400.
  • 68 Strachan D.P. Family size, infection and atopy: the first decade of the “hygiene hypothesis”. Thorax 2000; 55 (01) S2-S10.
  • 69 Björkstén B, Naaber P, Seep E. The intestinal microflora in allergic Estonian and Swedish 2 year-old children. Clin Exp Allergy 1999; 29: 342-346.
  • 70 Kim S.D, Drake-Lee A.B. Infection, allergy and the hygiene hypothesis: historical perspective. J Laringol Otol 2003; 117 (12) 946:950
  • 71 Cooper P.J, Chico M.E, Rodrigues L.C. et al. Risk factors for atopy among school children in a rural area of Latin America. Clin Exp Allergy 2004; 34 (06) 845-852.
  • 72 van den Biggelaar A.H, Rodrigues L.C, van Ree R. et al. Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Infect Dis 2004; 189 (05) 892-900.
  • 73 Cooper P.J, Chico M.E, Bland M, Griffin G.E, Nutman T.B. Allergic symptoms, atopy, and geohelminth infections in a rural area of Ecuador. Am J Respir Crit Care Med 2003; 168 (03) 313-317.
  • 74 Cooper P.J, Chico M.E, Rodrigues L.C. et al. Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics. J Allergy Clin Immunol 2003; 111 (05) 995-1000.
  • 75 Dagoye D, Bekele Z, Woldemichael K. et al. Wheezing, allergy, and parasite infection in children in urban and rural Ethiopia. Am J Respir Crit Care Med 2003; 167 (10) 1369-1373.
  • 76 Lodinová-Zádníková R, Cukrowska B, Tlaskalova-Hogenova H. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol 2003; 131 (03) 209-211.
  • 77 Palmer L.J, Celedón J.C. Wec. Ascaris lumbricoides infection is associated with increased risk of childhood asthma and atopy in rural China. Am J Respir Crit Care Med 2002; 165 (11) 1489-1493.
  • 78 Huang S.L, Tsai P.F, Yeh Y.F. Negative association of Enterobius infestation with asthma and rhinitis in primary school children in Taipei. Clin Exp Allergy 2002; 32 (07) 1029-1032.
  • 79 Matricardi P.M, Rosmini F, Panetta V, Ferrigno L, Bonini S. Hay fever and asthma in relation to markers of infection in the United States. J Allergy Clin Immunol 2002; 110 (03) 381-387.
  • 80 Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357 9262 1076-1079.
  • 81 Chan P.W, Anuar A.K, Fong M.Y, Debruyne J.A, Ibrahim J. Toxocara seroprevalence and childhood asthma among Malaysian children. Pediatr Int 2001; 43 (04) 350-353.
  • 82 Nyan O.A, Walraven G.E, Banya W.A. et al. Atopy, intestinal helminth infection and total serum IgE in rural and urban adult Gambian communities. Clin Exp Allergy 2001; 31 (11) 1672-1678.
  • 83 Scrivener S, Yemaneberhan H, Zebenigus M. et al. Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case–control study. Lancet 2001; 358 9292 1493-1499.
  • 84 Matricardi P.M, Rosmini F, Riondino S. et al. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ 2000; 320 7232 412-417.
  • 85 Araujo M.I, Lopes A.A, Medeiros M. et al. Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int Arch Allergy Immunol 2000; 123 (02) 145-148.
  • 86 van den Biggelaar A.H, van Ree R, Rodrigues L.C. et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000; 356 9243 1723-1727.
  • 87 Lynch N.R, Hagel I.A, Palenque M.E. et al. Relationship between helminthic infection and IgE response in atopic and nonatopic children in a tropical environment. J Allergy Clin Immunol 1998; 101 2 Pt 1 217-221.
  • 88 Matricardi P.M, Rosmini F, Ferrigno L. et al. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 1997; 314 7086 999-1003.
  • 89 Pritchard D.I, Shakib F, Walsh E.A, Smith S.J. Measurement of hookworm infection intensity and circulating levels of IgE and autoantibodies to IgE in atopics and nonatopics living in a parasitized community in Papua New Guinea. J Investig Allergol Clin Immunol 1994; 4 (05) 238-241.
  • 90 Di Prisco M.C, Hagel I, Lynch N.R, Barrios R.M, Alvarez N, López R. Possible relationship between allergic disease and infection by Giardia lamblia . Ann Allergy 1993; 70 (03) 210-213.
  • 91 Hagel I, Lynch N.R, Pérez M, Di Prisco M.C, López R, Rojas E. Modulation of the allergic reactivity of slum children by helminthic infection. Parasite Immunol 1993; 15 (06) 311-315.
  • 92 Kemp A, Björkstén B. Immune deviation and the hygiene hypothesis: a review of the epidemiological evidence. Pediatr Allergy Immunol 2003; 14 (02) 74-80.
  • 93 Sheikh A, Strachan D.P.. The hygiene theory: fact or fiction?. Curr Opin Otolaryngol Head Neck Surg 2004; 12 (03) 232-236.
  • 94 Laubereau B, Grote V, Hölscher G. et al. Vaccination against Haemophilus influenzae type b and atopy in east German schoolchildren. Eur J Med Res 2002; 7 (09) 387-392.
  • 95 Hurwitz EL, Hurwitz EL, Morgenstern H. Effects of diphtheria–tetanus–pertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States. J Manipulative Physiol Ther 2000; 23 (02) 81-90.
  • 96 Kemp T, Pearce N, Fitzharris P. et al. Is infant immunization a risk factor for childhood asthma or allergy?. Epidemiology 1997; 8 (06) 678-680.
  • 97 Jedrychowski W, Maugeri U, Jedrychowska-Bianchi I. Prospective epidemiologic study on respiratory diseases in children and immunization against measles. Int J Occup Med Environ Health 2004; 17 (02) 255-261.
  • 98 Maitra A, Sherriff A, Griffiths M, Henderson J. Avon longitudinal study of parents and children study team. Pertussis vaccination in infancy and asthma or allergy in later childhood: birth cohort study. BMJ 2004; 328 7445 925-926.
  • 99 Bager P, Rostgaard K, Nielsen N.M, Melbye M, Westergaard T. Age at bacille Calmette–Guérin vaccination and risk of allergy and asthma. Clin Exp Allergy 2003; 33 (11) 1512-1517.
  • 100 Bager P, Westergaard T, Rostgaard K, Nielsen N.M, Melbye M, Aaby P. Smallpox vaccination and risk of allergy and asthma. J Allergy Clin Immunol 2003; 111 (06) 1227-1231.
  • 101 Bernsen R.M, de Jongste J.C, van der Wouden J.C. Lower risk of atopic disorders in whole cell pertussis-vaccinated children. Eur Respir J 2003; 22 (06) 962-964.
  • 102 Grüber C, Illi S, Lau S. et al. Transient suppression of atopy in early childhood is associated with high vaccination coverage. Pediatrics 2003; 111 (03) e282-e288.
  • 103 Krause T.G, Hviid A. et al. BCG vaccination and risk of atopy. JAMA 2003; 289 (08) 1012-1015.
  • 104 Marks G.B, Ng K, Zhou J. et al. The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J Allergy Clin Immunol 2003; 111 (03) 541-549.
  • 105 Nilsson L, Kjellman N.I, Bjorkstén B. Allergic disease at the age of 7 years after pertussis vaccination in infancy: results from the follow-up of a randomized controlled trial of 3 vaccines. Arch Pediatr Adolesc Med 2003; 157 (12) 1184-1189.
  • 106 Cavallo G.P, Elia M, Giordano D, Baldi C, Cammarota R. Decrease of specific and total IgE levels in allergic patients after BCG vaccination: preliminary report. Arch Otolaryngol Head Neck Surg 2002; 128 (09) 1058-1060.
  • 107 Jang A.S, Son M.H. The association of airway hyperresponsiveness and tuberculin responses. Allergy 2002; 57 (04) 341-345.
  • 108 Anderson H.R, Poloniecki J.D, Strachan D.P, Beasley R, Björkstén B, Asher M.I. Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am J Public Health 2001; 91 (07) 1126-1129.
  • 109 Arkwright P.D, David T.J. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol 2001; 107 (03) 531-534.
  • 110 Grüber C, Kulig M, Bergmann R, Guggenmoos-Holzmann I, Wahn U. Delayed hypersensitivity to tuberculin, total immunoglobulin E, specific sensitization, and atopic manifestation in longitudinally followed early Bacille–Calmette–Guérin-vaccinated and nonvaccinated children. Pediatrics 2001; 107 (03) E36.
  • 111 Wong G.W, Hui D.S, Tam C.M. et al. Asthma, atopy and tuberculin responses in Chinese schoolchildren in Hong Kong. Thorax 2001; 56 (10) 770-773.
  • 112 Aaby P, Shaheen S.O, Heyes C.B. et al. Early BCG vaccination and reduction in atopy in Guinea–Bissau. Clin Exp Allergy 2000; 30 (05) 644-650.
  • 113 Assa’ad A, Lierl M. Effect of acellular pertussis vaccine on the development of allergic sensitization to environmental allergens in adults. J Allergy Clin Immunol 2002; 105 1 Pt 1 170-175.
  • 114 Ryan E.J, Nilsson L, Kjellman N, Gothefors L, Mills K.H. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens. Clin Exp Immunol 2000; 121 (02) 193-200.
  • 115 Henderson J, North K, Griffiths M, Harvey I, Golding J. Pertussis vaccination and wheezing illnesses in young children: prospective cohort study. The Longitudinal Study of Pregnancy and Childhood Team. BMJ 1999; 18 7192 1173-1176.
  • 116 Alm J.S, Lilja G, Pershagen G, Scheynius A. Early BCG vaccination and development of atopy. Lancet 1997; 350 9075 400-403.
  • 117 Grüber C, Nilsson L, Björkstén B. Do early childhood immunizations influence the development of atopy and do they cause allergic reactions?. Pediatr Allergy Immunol 2001; 12 (06) 296-311.
  • 118 Gangarosa E.J, Galezka A.M, Wolfe C.R. et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 1998; 351: 356-361.
  • 119 Vitek C.R, Pascual B, Baughman A.L, Murphy T.V. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Inf Dis J 2003; 22: 628-634.
  • 120 Rall G.F. Measles vírus 1998–2002: progress and controversy. Annu Rev Micbrobiol 2003; 57: 343-367.
  • 121 Karmaus W, Botezan C. Does a higher number of siblings protect against the development of allergy and asthma? A review. J Epidemiol Community Health 2002; 56 (03) 209-217.
  • 122 Koppen S, de Groot R, Neijens H.J, Nagelkerke N, van Eden W, Rümke H.C. No epidemiological evidence for infant vaccinations to cause allergic disease. Vaccine 2004; 22 25–26 3375-3385.
  • 123 Rottem M, Shoenfeld Y. Vaccination and allergy. Curr Opin Otolaryngol Head Neck Surg 2004; 12 (03) 223-231.
  • 124 Hahnemann S. Die chronischen Krankheiten, ihre eigentüml. Natur u. homöopath. Heilung, vol 1, 2a edn. Heidelberg: Haug, 1835, 4a impressão, 1988, p 166.
  • 125 Hahnemann S. Organon der Heilkunst: aude sapere, 6a edn. Compilada por Richard Haehl, Leipzig: Schwuabe, 1921, Heidelberg: Haug, 1988, parágr. 46.
  • 126 Adler U.C, Ambrosio Jr E., Anelli I.M, Cappello E, César A.T, Guimarães E.C. Vacina: agressão isopática ou cura homeopática por antecipação?. Rev Hom APH 1994; 59 (01) 3-8.
  • 127 Adler U.C, Ambrosio J.r, Anelli I.M, Cappello E, César A.T, Guimarães E.C. Vaccination: the homeopathy developed by Jenner. Homoeopathica, J LMHI 1995; Winter: 12-16.
  • 128 Burnett J.C. Vaccinosis and its Cure by Thuya. Health Science Press; 1960. p 83
  • 129 Leclerc C. New approaches in vaccine development. Comp Immunol Microbiol Infect Dis 2003; 26 5–6 329-341.
  • 130 Gaublomme K. Vaccinations: the call of the sirens. Homoeopathica, Journal of LMHI 1995; Winter: 17-25.
  • 131 Coulter H.L. Vaccination and sociopathy. Homoeopathica, Journal of LMHI 1994; Summer: 20-23.
  • 132 Calam R, Gregg L, Simpson B, Morris J, Woodcock A, Custovic A. Childhood asthma, behavior problems, and family functioning. J Allergy Clin Immunol 2003; 112 (03) 499-504.
  • 133 Buske-Kirschbaum A, Gierens A, Höllig H, Hellhammer D.H. Stress-induced immunomodulation is altered in patients with atopic dermatitis. J Neuroimmunol 2002; 129 1–2 161-167.
  • 134 Buske-Kirschbaum A, Geiben A, Hellhammer D. Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom 2001; 70 (01) 6-16.
  • 135 Ring J, Krämer U, Schäfer T, Abeck D, Vieluf D, Behrendt H. Environmental risk factors for respiratory and skin atopy: results from epidemiological studies in former East and West Germany. Int Arch Allergy Immunol 1999; 118 2–4 403-407.
  • 136 LeSon S, Gershwin M.E. Risk factors for asthmatic patients requiring intubation. III. Observations in young adults. J Asthma 1996; 33 (01) 27-35.
  • 137 Michel F.B. Psychology of the allergic patient. Allergy 1994; 49 (18) 28-30.
  • 138 Eksi A, Molzan J, Savasir I, Güler N. Psychological adjustment of children with mild and moderately severe asthma. Eur Child Adolesc Psychiatry 1995; 4 (02) 77-84.